<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Genetic disorders &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/genetic-disorders/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 24 Jan 2026 04:02:15 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Genetic disorders &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Screening and Treating Hereditary Hemorrhagic Telangiectasia Early</title>
		<link>https://bioengineer.org/screening-and-treating-hereditary-hemorrhagic-telangiectasia-early/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 24 Jan 2026 04:01:51 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Cascade Screening]]></category>
		<category><![CDATA[Early Intervention]]></category>
		<category><![CDATA[Genetic disorders]]></category>
		<category><![CDATA[Hereditary Hemorrhagic Telangiectasia]]></category>
		<category><![CDATA[Presymptomatic Treatment]]></category>
		<category><![CDATA[public health initiatives]]></category>
		<guid isPermaLink="false">https://bioengineer.org/screening-and-treating-hereditary-hemorrhagic-telangiectasia-early/</guid>

					<description><![CDATA[Hereditary hemorrhagic telangiectasia (HHT) presents a fascinating area of medical research that revolves around genetic predisposition to abnormal blood vessel formation, leading to complications such as bleeding and, in some cases, significant morbidity. Recent studies highlight not only the clinical manifestations of this condition, but also the potential benefits of early detection and intervention. In [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">320151</post-id>	</item>
		<item>
		<title>Long-Read Sequencing Uncovers Congenital Adrenal Hyperplasia in Newborns</title>
		<link>https://bioengineer.org/long-read-sequencing-uncovers-congenital-adrenal-hyperplasia-in-newborns/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 23 Jan 2026 04:03:46 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Congenital adrenal hyperplasia]]></category>
		<category><![CDATA[Genetic disorders]]></category>
		<category><![CDATA[Genetics]]></category>
		<category><![CDATA[long-read sequencing]]></category>
		<category><![CDATA[Makale içeriğine ve anahtar kelimelere göre en uygun 5 etiket: **Congenital Adrenal Hyperplasia]]></category>
		<category><![CDATA[Makale içeriğine ve anahtar kelimelere göre en uygun 5 etiket: **Long-read sequencing]]></category>
		<category><![CDATA[Newborn Screening]]></category>
		<category><![CDATA[Pediatric Medicine]]></category>
		<category><![CDATA[Pediatric medicine** **Açıklama:** 1. **Long-read sequencing:** Makalenin temel teknolojik metodolojisi ve ana vurgusu. 2. **Congenital adrenal hyperplasia (CAH):** Araştırmanın odak]]></category>
		<guid isPermaLink="false">https://bioengineer.org/long-read-sequencing-uncovers-congenital-adrenal-hyperplasia-in-newborns/</guid>

					<description><![CDATA[In a groundbreaking study, researchers have embarked on an unprecedented exploration of congenital adrenal hyperplasia (CAH) through the lens of advanced genomic technologies. This sophisticated investigation, led by a team including Liang, Zhu, and Liang, delves into a cohort comprising over 21,000 newborns, aiming to enhance our understanding of CAH and revolutionize early detection protocols [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">319631</post-id>	</item>
	</channel>
</rss>
